- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05699096
Perfluorooctyl Bromide Which Empowers the Liquid to Flat the Detached Retina and Displace the Underneath Fluids Anteriorly
January 24, 2023 updated by: EL Romany Ophthalmics Factory
Perfluorooctyl Bromideessential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset
Perfluorohexyloctaneis Essential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: El R Ophthalmics
- Phone Number: +201212331343
- Email: drmina@elromanyophthalmics.com
Study Locations
-
-
Kubri EL Kubba
-
Cairo, Kubri EL Kubba, Egypt, 11711
- Recruiting
- Girgis Boules
-
Contact:
- Girgis Boules
- Email: elromanyophthalmics@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
primary care clinic
Description
Inclusion Criteria:
- - Is 20 years or older Has been diagnosed with Keratoconus; Has no other active ocular disease; Is not pregnant or nursing;
Exclusion Criteria:
- Is under the age of 20 Has best corrected visual acuity outside 20/400; Pregnant or nursing at the time of enrollment in the study;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
---|
eye surgery ,Vitreoretinal Surgery and Related Ocular Inflammation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
flat the detached retina and displace the underneath fluids anteriorly
Time Frame: Base line
|
the effect of Perfluorooctyl Bromide on the retina ,under ophthalmic microscope check the flatted retina
|
Base line
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
July 1, 2023
Primary Completion (Anticipated)
July 1, 2025
Study Completion (Anticipated)
July 1, 2026
Study Registration Dates
First Submitted
January 15, 2023
First Submitted That Met QC Criteria
January 24, 2023
First Posted (Estimate)
January 26, 2023
Study Record Updates
Last Update Posted (Estimate)
January 26, 2023
Last Update Submitted That Met QC Criteria
January 24, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ROPFO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Retinal Disease
-
LKC Technologies, Inc.Unknown
-
University Hospital, Strasbourg, FranceNot yet recruitingInherited Retinal DiseaseFrance
-
Retinagenix HoldingsWithdrawnRetinal DisorderUnited States
-
University Hospital Inselspital, BerneCompletedRetinal DiseaseSwitzerland
-
Janssen Research & Development, LLCRecruitingInherited Retinal DiseasesUnited States, Korea, Republic of, Canada, Spain, Denmark, Germany, France, Italy, Israel, Austria, United Kingdom
-
Topcon Medical Systems, Inc.CompletedNormal Eyes | Eyes With Glaucoma | Eyes With Retinal DiseaseUnited States
-
Gangnam Severance HospitalCompletedInherited Retinal Dystrophy Primarily Involving Sensory Retina | Inherited Retinal Dystrophy Primarily Involving Retinal Pigment EpitheliumKorea, Republic of
-
Luzerner KantonsspitalCompletedRetinal Disease | Eye DiseaseSwitzerland
-
University Hospital Inselspital, BerneUniversity of Bern; Haag-Streit AGNot yet recruitingRetinal DiseaseSwitzerland
-
Hopital FochRecruiting